H. R. 266 

One Hundred Sixteenth Congress 

of the 

United States of America 

AT THE SECOND SESSION 

Begun and held at the City of Washington on Friday, 

the third day of January, two thousand and twenty 

An Act 

Making appropriations for the Department of the Interior, environment, and related 

agencies for the fiscal year ending September 30, 2019, and for other purposes. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. SHORT TITLE. 

This Act may be cited as the ‘‘Paycheck Protection Program 

and Health Care Enhancement Act’’. 

SEC. 2. TABLE OF CONTENTS. 

The table of contents for this Act is as follows: 

Sec. 1. Short title. 

Sec. 2. Table of contents. 

Sec. 3. References. 

DIVISION A—SMALL BUSINESS PROGRAMS 

Sec. 101. Amendments to the Paycheck Protection Program, economic injury disaster loans, and emergency grants. 

Sec. 102. Emergency designation. 

DIVISION B—ADDITIONAL EMERGENCY APPROPRIATIONS FOR 

CORONAVIRUS RESPONSE 

SEC. 3. REFERENCES. 

Except as expressly provided otherwise, any reference to ‘‘this 

Act’’ contained in any division of this Act shall be treated as 

referring only to the provisions of that division. 

DIVISION A—SMALL BUSINESS 

PROGRAMS 

SEC. 101. AMENDMENTS TO THE PAYCHECK PROTECTION PROGRAM, 

ECONOMIC INJURY DISASTER LOANS, AND EMERGENCY 

GRANTS. 

(a) INCREASED AUTHORITY FOR COMMITMENTS AND APPROPRIA- TIONS FOR PAYCHECK PROTECTION PROGRAM.—Title I of division 

A of the Coronavirus Aid, Relief, and Economic Security Act (Public 

Law 116–136) is amended— 

(1) in section 1102(b)(1), by striking ‘‘$349,000,000,000’’ and inserting ‘‘$659,000,000,000’’; and (2) in section 1107(a)(1), by striking ‘‘$349,000,000,000’’ and inserting ‘‘$670,335,000,000’’. 

(b) INCREASED AUTHORIZATION FOR EMERGENCY EIDL 

GRANTS.—Section 1110(e)(7) of division A of the Coronavirus Aid, 
H. R. 266—2 

Relief, and Economic Security Act (Public Law 116–136) is amended 

by striking ‘‘$10,000,000,000’’ and inserting ‘‘$20,000,000,000’’. 

(c) ELIGIBILITY OF AGRICULTURAL ENTERPRISES FOR ECONOMIC

INJURY DISASTER LOANS AND EMERGENCY GRANTS.—Section 

1110(a)(2) of division A of the Coronavirus Aid, Relief, and Economic 

Security Act (Public Law 116–136) is amended— 

(1) in subparagraph (D), by striking ‘‘or’’ at the end; 

(2) in subparagraph (E), by striking the period at the 

end and inserting ‘‘; or’’; and 

(3) by adding at the end the following: 

‘‘(F) an agricultural enterprise (as defined in section 

18(b) of the Small Business Act (15 U.S.C. 647(b)) with 

not more than 500 employees.’’. 

(d) SET ASIDE FOR INSURED DEPOSITORY INSTITUTIONS, CREDIT

UNIONS, AND COMMUNITY FINANCIAL INSTITUTIONS.—Section 

7(a)(36) of the Small Business Act (15 U.S.C. 636(a)(36)) is 

amended— 

(1) in subparagraph (A)— 

(A) in clause (viii), by striking ‘‘and’’ at the end; 

(B) in clause (ix), by striking the period at the end 

and inserting a semicolon; and 

(C) by adding at the end the following: 

‘‘(x) the term ‘community development financial 

institution’ has the meaning given the term in section 

103 of the Riegle Community Development and Regulatory Improvement Act of 1994 (12 U.S.C. 4702)); 

‘‘(xi) the term ‘community financial institutions’ 

means— 

‘‘(I) a community development financial 

institution; 

‘‘(II) a minority depository institution, as 

defined in section 308 of the Financial Institutions 

Reform, Recovery, and Enforcement Act of 1989 

(12 U.S.C. 1463 note); 

‘‘(III) a development company that is certified 

under title V of the Small Business Investment 

Act of 1958 (15 U.S.C. 695 et seq.); and 

‘‘(IV) an intermediary, as defined in section 

7(m)(11); and 

‘‘(xii) the term ‘credit union’ means a State credit 

union or a Federal credit union, as those terms are 

defined, respectively, in section 101 of the Federal 

Credit Union Act (12 U.S.C. 1752).’’; and 

(2) by adding at the end the following: 

‘‘(S) SET-ASIDE FOR INSURED DEPOSITORY INSTITUTIONS, 

CREDIT UNIONS, AND COMMUNITY FINANCIAL INSTITUTIONS.— 

‘‘(i) INSURED DEPOSITORY INSTITUTIONS AND CREDIT

UNIONS.—In making loan guarantees under this paragraph after the date of enactment of this clause, the 

Administrator shall guarantee not less than 

$30,000,000,000 in loans made by— 

‘‘(I) insured depository institutions with 

consolidated assets of not less than 

$10,000,000,000 and less than $50,000,000,000; 

and 
H. R. 266—3 

‘‘(II) credit unions with consolidated assets of 

not less than $10,000,000,000 and less than 

$50,000,000,000. 

‘‘(ii) COMMUNITY FINANCIAL INSTITUTIONS, SMALL

INSURED DEPOSITORY INSTITUTIONS, AND CREDIT

UNIONS.—In making loan guarantees under this paragraph after the date of enactment of this clause, the 

Administrator shall guarantee not less than 

$30,000,000,000 in loans made by— 

‘‘(I) community financial institutions; 

‘‘(II) insured depository institutions with 

consolidated assets of less than $10,000,000,000; 

and 

‘‘(III) credit unions with consolidated assets 

of less than $10,000,000,000.’’. 

SEC. 102. EMERGENCY DESIGNATION. 

(a) IN GENERAL.—The amounts provided under this division 

are designated as an emergency requirement pursuant to section 

4(g) of the Statutory Pay-As-You-Go Act of 2010 (2 U.S.C. 933(g)). 

(b) DESIGNATION IN SENATE.—In the Senate, this division is 

designated as an emergency requirement pursuant to section 

4112(a) of H. Con. Res. 71 (115th Congress), the concurrent resolution on the budget for fiscal year 2018. 

DIVISION B—ADDITIONAL EMERGENCY 

APPROPRIATIONS FOR CORONAVIRUS RESPONSE 

The following sums are hereby appropriated, out of any money 

in the Treasury not otherwise appropriated, for the fiscal year 

ending September 30, 2020, and for other purposes, namely: 

TITLE I 

DEPARTMENT OF HEALTH AND HUMAN SERVICES 

OFFICE OF THE SECRETARY

PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND

(INCLUDING TRANSFER OF FUNDS)

For an additional amount for ‘‘Public Health and Social Services 

Emergency Fund’’, $75,000,000,000, to remain available until 

expended, to prevent, prepare for, and respond to coronavirus, 

domestically or internationally, for necessary expenses to reimburse, 

through grants or other mechanisms, eligible health care providers 

for health care related expenses or lost revenues that are attributable to coronavirus: Provided, That these funds may not be used 

to reimburse expenses or losses that have been reimbursed from 

other sources or that other sources are obligated to reimburse: 

Provided further, That recipients of payments under this paragraph 

in this Act shall submit reports and maintain documentation as 

the Secretary of Health and Human Services (referred to in this 

paragraph as the ‘‘Secretary’’) determines are needed to ensure 

compliance with conditions that are imposed by this paragraph 

in this Act for such payments, and such reports and documentation 

shall be in such form, with such content, and in such time as 
H. R. 266—4 

the Secretary may prescribe for such purpose: Provided further, 

That ‘‘eligible health care providers’’ means public entities, Medicare 

or Medicaid enrolled suppliers and providers, and such for-profit 

entities and not-for-profit entities not otherwise described in this 

proviso as the Secretary may specify, within the United States 

(including territories), that provide diagnoses, testing, or care for 

individuals with possible or actual cases of COVID–19: Provided 

further, That the Secretary shall, on a rolling basis, review applications and make payments under this paragraph in this Act: Provided further, That funds appropriated under this paragraph in 

this Act shall be available for building or construction of temporary 

structures, leasing of properties, medical supplies and equipment 

including personal protective equipment and testing supplies, 

increased workforce and trainings, emergency operation centers, 

retrofitting facilities, and surge capacity: Provided further, That, 

in this paragraph, the term ‘‘payment’’ means a pre-payment, 

prospective payment, or retrospective payment, as determined 

appropriate by the Secretary: Provided further, That payments 

under this paragraph in this Act shall be made in consideration 

of the most efficient payment systems practicable to provide emergency payment: Provided further, That to be eligible for a payment 

under this paragraph in this Act, an eligible health care provider 

shall submit to the Secretary an application that includes a statement justifying the need of the provider for the payment and 

the eligible health care provider shall have a valid tax identification 

number: Provided further, That, not later than 3 years after final 

payments are made under this paragraph in this Act, the Office 

of Inspector General of the Department of Health and Human 

Services shall transmit a final report on audit findings with respect 

to this program to the Committees on Appropriations of the House 

of Representatives and the Senate: Provided further, That nothing 

in this paragraph limits the authority of the Inspector General 

or the Comptroller General to conduct audits of interim payments 

at an earlier date: Provided further, That not later than 60 days 

after the date of enactment of this Act, the Secretary shall provide 

a report to the Committees on Appropriations of the House of 

Representatives and the Senate on obligation of funds, including 

obligations to such eligible health care providers summarized by 

State of the payment receipt: Provided further, That such reports 

shall be updated and submitted to such Committees every 60 days 

until funds are expended: Provided further, That such amount 

is designated by the Congress as being for an emergency requirement pursuant to section 251(b)(2)(A)(i) of the Balanced Budget 

and Emergency Deficit Control Act of 1985. 

For an additional amount for ‘‘Public Health and Social Services 

Emergency Fund’’, $25,000,000,000, to remain available until 

expended, to prevent, prepare for, and respond to coronavirus, 

domestically or internationally, for necessary expenses to research, 

develop, validate, manufacture, purchase, administer, and expand 

capacity for COVID–19 tests to effectively monitor and suppress 

COVID–19, including tests for both active infection and prior exposure, including molecular, antigen, and serological tests, the manufacturing, procurement and distribution of tests, testing equipment 

and testing supplies, including personal protective equipment 

needed for administering tests, the development and validation 

of rapid, molecular point-of-care tests, and other tests, support 

for workforce, epidemiology, to scale up academic, commercial, 
H. R. 266—5 

public health, and hospital laboratories, to conduct surveillance 

and contact tracing, support development of COVID–19 testing 

plans, and other related activities related to COVID–19 testing: 

Provided, That of the amount appropriated under this paragraph 

in this Act, not less than $11,000,000,000 shall be for States, 

localities, territories, tribes, tribal organizations, urban Indian 

health organizations, or health service providers to tribes for necessary expenses to develop, purchase, administer, process, and analyze COVID–19 tests, including support for workforce, epidemiology, 

use by employers or in other settings, scale up of testing by public 

health, academic, commercial, and hospital laboratories, and 

community-based testing sites, health care facilities, and other entities engaged in COVID–19 testing, conduct surveillance, trace contacts, and other related activities related to COVID–19 testing: 

Provided further, That of the amount identified in the preceding 

proviso, not less than $2,000,000,000 shall be allocated to States, 

localities, and territories according to the formula that applied 

to the Public Health Emergency Preparedness cooperative agreement in fiscal year 2019, not less than $4,250,000,000 shall be 

allocated to States, localities, and territories according to a formula 

methodology that is based on relative number of cases of COVID– 

19, and not less than $750,000,000 shall be allocated in coordination 

with the Director of the Indian Health Service, to tribes, tribal 

organizations, urban Indian health organizations, or health service 

providers to tribes: Provided further, That the Secretary of Health 

and Human Services (referred to in this paragraph as the ‘‘Secretary’’) may satisfy the funding thresholds outlined in the first 

and second provisos under this paragraph in this Act by making 

awards through other grant or cooperative agreement mechanisms: 

Provided further, That not later than 30 days after the date of 

enactment of this Act, the Governor or designee of each State, 

locality, territory, tribe, or tribal organization receiving funds pursuant to this Act shall submit to the Secretary its plan for COVID– 

19 testing, including goals for the remainder of calendar year 2020, 

to include: (1) the number of tests needed, month-by-month, to 

include diagnostic, serological, and other tests, as appropriate; (2) 

month-by-month estimates of laboratory and testing capacity, 

including related to workforce, equipment and supplies, and available tests; and (3) a description of how the State, locality, territory, 

tribe, or tribal organization will use its resources for testing, 

including as it relates to easing any COVID–19 community mitigation policies: Provided further, That the Secretary shall submit 

such formula methodology identified in the first proviso under this 

paragraph in this Act to the Committees on Appropriations of 

the House of Representatives and the Senate one day prior to 

awarding such funds: Provided further, That such funds identified 

in the first and second provisos under this paragraph in this Act 

shall be allocated within 30 days of the date of enactment of 

this Act: Provided further, That of the amount appropriated under 

this paragraph in this Act, not less than $1,000,000,000 shall be 

transferred to the ‘‘Centers for Disease Control and Prevention— 

CDC-Wide Activities and Program Support’’ for surveillance, epidemiology, laboratory capacity expansion, contact tracing, public 

health data surveillance and analytics infrastructure modernization, 

disseminating information about testing, and workforce support 

necessary to expand and improve COVID–19 testing: Provided further, That of the amount appropriated under this paragraph in 
H. R. 266—6 

this Act, not less than $306,000,000 shall be transferred to the 

‘‘National Institutes of Health—National Cancer Institute’’ to 

develop, validate, improve, and implement serological testing and 

associated technologies for the purposes specified under this paragraph in this Act: Provided further, That of the amount appropriated 

under this paragraph in this Act, not less than $500,000,000 shall 

be transferred to the ‘‘National Institutes of Health—National 

Institute of Biomedical Imaging and Bioengineering’’ to accelerate 

research, development, and implementation of point of care and 

other rapid testing related to coronavirus: Provided further, That 

of the amount appropriated under this paragraph in this Act, not 

less than $1,000,000,000 shall be transferred to the ‘‘National 

Institutes of Health—Office of the Director’’ to develop, validate, 

improve, and implement testing and associated technologies; to 

accelerate research, development, and implementation of point of 

care and other rapid testing; and for partnerships with governmental and non-governmental entities to research, develop, and 

implement the activities outlined in this proviso: Provided further, 

That funds in the preceding proviso may be transferred to the 

accounts of the Institutes and Centers of the National Institutes 

of Health (referred to in this paragraph as the ‘‘NIH’’) for the 

purposes specified in the preceding proviso: Provided further, That 

the transfer authority provided in the preceding proviso is in addition to all other transfer authority available to the NIH: Provided 

further, That of the amount appropriated under this paragraph 

in this Act, not less than $1,000,000,000 shall be available to 

the Biomedical Advanced Research and Development Authority for 

necessary expenses of advanced research, development, manufacturing, production, and purchase of diagnostic, serologic, or other 

COVID–19 tests or related supplies, and other activities related 

to COVID–19 testing at the discretion of the Secretary: Provided 

further, That of the amount appropriated under this paragraph 

in this Act, $22,000,000, shall be transferred to the ‘‘Department 

of Health and Human Services—Food and Drug Administration— 

Salaries and Expenses’’ to support activities associated with diagnostic, serological, antigen, and other tests, and related administrative activities: Provided further, That the amount appropriated 

under this paragraph in this Act may be used for grants for the 

rent, lease, purchase, acquisition, construction, alteration, renovation, or equipping of non-federally owned facilities to improve 

preparedness and response capability at the State and local level 

for diagnostic, serologic, or other COVID–19 tests, or related supplies: Provided further, That the amount appropriated under this 

paragraph in this Act may be used for construction, alteration, 

renovation, or equipping of non-federally owned facilities for the 

production of diagnostic, serologic, or other COVID–19 tests, or 

related supplies, where the Secretary determines that such a contract is necessary to secure, or for the production of, sufficient 

amounts of such tests or related supplies: Provided further, That 

funds appropriated under this paragraph in this Act may be used 

for purchase of medical supplies and equipment, including personal 

protective equipment and testing supplies to be used for administering tests, increased workforce and trainings, emergency operation centers, and surge capacity for diagnostic, serologic, or other 

COVID–19 tests, or related supplies: Provided further, That products purchased with funds appropriated under this paragraph in 

this Act may, at the discretion of the Secretary, be deposited in 
H. R. 266—7 

the Strategic National Stockpile under section 319F–2 of the Public 

Health Service Act: Provided further, That of the amount appropriated under this paragraph in this Act, $600,000,000 shall be 

transferred to ‘‘Health Resources and Services Administration— 

Primary Health Care’’ for grants under the Health Centers program, 

as defined by section 330 of the Public Health Service Act, and 

for grants to federally qualified health centers, as defined in section 

1861(aa)(4)(B) of the Social Security Act: Provided further, That 

sections 330(e)(6)(A)(iii), 330(e)(6)(B)(iii), and 330(r)(2)(B) of the 

Public Health Service Act shall not apply to funds provided under 

the previous proviso: Provided further, That of the amount appropriated under this paragraph in this Act, $225,000,000 shall be 

used to provide additional funding for COVID–19 testing and 

related expenses, through grants or other mechanisms, to rural 

health clinics as defined in section 1861(aa)(2) of the Social Security 

Act, with such funds also available to such entities for building 

or construction of temporary structures, leasing of properties, and 

retrofitting facilities as necessary to support COVID–19 testing: 

Provided further, That such funds shall be distributed using the 

procedures developed for the Provider Relief Fund authorized under 

the third paragraph under this heading in division B of the 

Coronavirus Aid, Relief, and Economic Security Act (Public Law 

116–136); may be distributed using contracts or agreements established for such program; and shall be subject to the process requirements applicable to such program: Provided further, That the Secretary may specify a minimum amount for each eligible entity 

accepting assistance under the two previous provisos: Provided 

further, That up to $1,000,000,000 of funds provided under this 

paragraph in this Act may be used to cover the cost of testing 

for the uninsured, using the definitions applicable to funds provided 

under this heading in Public Law 116–127: Provided further, That 

not later than 21 days after the date of enactment of this Act, 

the Secretary, in coordination with other appropriate departments 

and agencies, shall issue a report on COVID–19 testing: Provided 

further, That such report shall include data on demographic 

characteristics, including, in a de-identified and disaggregated 

manner, race, ethnicity, age, sex, geographic region and other relevant factors of individuals tested for or diagnosed with COVID– 

19, to the extent such information is available: Provided further, 

That such report shall include information on the number and 

rates of cases, hospitalizations, and deaths as a result of COVID– 

19: Provided further, That such report shall be submitted to the 

Committees on Appropriations of the House and Senate, and the 

Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions 

of the Senate, and updated and resubmitted to such Committees, 

as necessary, every 30 days until the end of the COVID–19 public 

health emergency first declared by the Secretary on January 31, 

2020: Provided further, That not later than 180 days after the 

date of enactment of this Act, the Secretary shall issue a report 

on the number of positive diagnoses, hospitalizations, and deaths 

as a result of COVID–19, disaggregated nationally by race, ethnicity, age, sex, geographic region, and other relevant factors: Provided further, That such report shall include epidemiological analysis of such data: Provided further, That not later than 30 days 

after the date of the enactment of this Act, the Secretary, in 

coordination with other departments and agencies, as appropriate, 
H. R. 266—8 

shall report to the Committees on Appropriations of the House 

and Senate, the Committee on Energy and Commerce of the House 

of Representatives, and the Committee on Health, Education, Labor, 

and Pensions of the Senate on a COVID–19 strategic testing plan: 

Provided further, That such plan shall assist States, localities, 

territories, tribes, tribal organizations, and urban Indian health 

organizations, in understanding COVID–19 testing for both active 

infection and prior exposure, including hospital-based testing, highcomplexity laboratory testing, point-of-care testing, mobile-testing 

units, testing for employers and other settings, and other tests 

as necessary: Provided further, That such plan shall include estimates of testing production that account for new and emerging 

technologies, as well as guidelines for testing: Provided further, 

That such plan shall address how the Secretary will increase 

domestic testing capacity, including testing supplies; and address 

disparities in all communities: Provided further, That such plan 

shall outline Federal resources that are available to support the 

testing plans of each State, locality, territory, tribe, tribal organization, and urban Indian health organization: Provided further, That 

such plan shall be updated every 90 days until funds are expended: 

Provided further, That such amount is designated by the Congress 

as being for an emergency requirement pursuant to section 

251(b)(2)(A)(i) of the Balanced Budget and Emergency Deficit Control Act of 1985. 

GENERAL PROVISIONS—THIS TITLE 

(INCLUDING TRANSFER OF FUNDS)

SEC. 101. The requirements, authorities, and conditions 

described in sections 18108, 18109, and 18112 of division B of 

the Coronavirus Aid, Relief, and Economic Security Act (Public 

Law 116–136) shall apply to funds appropriated in this Act to 

the Department of Health and Human Services. 

SEC. 102. Funds appropriated by this Act under the heading 

‘‘Department of Health and Human Services’’, except for the 

amounts specified in the first paragraph and the first and second 

provisos in the second paragraph under the heading ‘‘Public Health 

and Social Services Emergency Fund’’, may be transferred to, and 

merged with, other appropriation accounts under the headings ‘‘Centers for Disease Control and Prevention’’, ‘‘Public Health and Social 

Services Emergency Fund’’, ‘‘Food and Drug Administration’’, and 

‘‘National Institutes of Health’’ to prevent, prepare for, and respond 

to coronavirus following consultation with the Office of Management 

and Budget: Provided, That the Committees on Appropriations of 

the House of Representatives and the Senate shall be notified 

10 days in advance of any such transfer: Provided further, That, 

upon a determination that all or part of the funds transferred 

from an appropriation by this Act are not necessary, such amounts 

may be transferred back to that appropriation: Provided further, 

That none of the funds made available by this Act may be transferred pursuant to the authority in section 205 of division A of 

Public Law 116–94 or section 241(a) of the Public Health Service 

Act. 

SEC. 103. Of the funds appropriated by this Act under the 

heading ‘‘Public Health and Social Services Emergency Fund’’, up 

to $6,000,000 shall be transferred to, and merged with, funds made 
H. R. 266—9 

available under the heading ‘‘Office of the Secretary, Office of 

Inspector General’’, and shall remain available until expended, for 

oversight of activities supported with funds appropriated to the 

Department of Health and Human Services to prevent, prepare 

for, and respond to coronavirus, domestically or internationally: 

Provided, That the Inspector General of the Department of Health 

and Human Services shall consult with the Committees on Appropriations of the House of Representatives and the Senate prior 

to obligating such funds: Provided further, That the transfer 

authority provided by this section is in addition to any other transfer 

authority provided by law. 

TITLE II 

INDEPENDENT AGENCIES 

SMALL BUSINESS ADMINISTRATION

SALARIES AND EXPENSES

For an additional amount for ‘‘Salaries and Expenses’’, 

$2,100,000,000, to remain available until September 30, 2021, to 

prevent, prepare for, and respond to coronavirus, domestically or 

internationally: Provided, That such amount is designated by the 

Congress as being for an emergency requirement pursuant to section 

251(b)(2)(A)(i) of the Balanced Budget and Emergency Deficit Control Act of 1985. 

DISASTER LOANS PROGRAM ACCOUNT

For an additional amount for ‘‘Disaster Loans Program Account’’ 

for the cost of direct loans authorized by section 7(b) of the Small 

Business Act, $50,000,000,000, to remain available until expended, 

to prevent, prepare for, and respond to coronavirus, domestically 

or internationally: Provided, That such amount is designated by 

the Congress as being for an emergency requirement pursuant 

to section 251(b)(2)(A)(i) of the Balanced Budget and Emergency 

Deficit Control Act of 1985. 

EMERGENCY EIDL GRANTS

For an additional amount for ‘‘Emergency EIDL Grants’’ for 

the cost of emergency EIDL grants authorized by section 1110 

of division A of the CARES Act (Public Law 116–136), 

$10,000,000,000, to remain available until expended, to prevent, 

prepare for, and respond to coronavirus, domestically or internationally: Provided, That such amount is designated by the Congress 

as being for an emergency requirement pursuant to section 

251(b)(2)(A)(i) of the Balanced Budget and Emergency Deficit Control Act of 1985. 

TITLE III 

GENERAL PROVISIONS—THIS ACT 

SEC. 301. Each amount appropriated or made available by 

this Act is in addition to amounts otherwise appropriated for the 

fiscal year involved. 
H. R. 266—10 

SEC. 302. No part of any appropriation contained in this Act 

shall remain available for obligation beyond the current fiscal year 

unless expressly so provided herein. 

SEC. 303. Unless otherwise provided for by this Act, the additional amounts appropriated by this Act to appropriations accounts 

shall be available under the authorities and conditions applicable 

to such appropriations accounts for fiscal year 2020. 

SEC. 304. Notwithstanding any other provision of law, funds 

made available in this Act, or transferred pursuant to authorization 

granted in this Act, may only be used to prevent, prepare for, 

and respond to coronavirus. 

SEC. 305. In this Act, the term ‘‘coronavirus’’ means SARS– 

CoV–2 or another coronavirus with pandemic potential. 

SEC. 306. Each amount designated in this Act by the Congress 

as being for an emergency requirement pursuant to section 

251(b)(2)(A)(i) of the Balanced Budget and Emergency Deficit Control Act of 1985 shall be available (or rescinded or transferred, 

if applicable) only if the President subsequently so designates all 

such amounts and transmits such designations to the Congress. 

SEC. 307. Any amount appropriated by this Act, designated 

by the Congress as an emergency requirement pursuant to section 

251(b)(2)(A)(i) of the Balanced Budget and Emergency Deficit Control Act of 1985 and subsequently so designated by the President, 

and transferred pursuant to transfer authorities provided by this 

Act shall retain such designation. 

BUDGETARY EFFECTS

SEC. 308. (a) STATUTORY PAYGO SCORECARDS.—The budgetary 

effects of this division shall not be entered on either PAYGO scorecard maintained pursuant to section 4(d) of the Statutory Pay 

As-You-Go Act of 2010. 

(b) SENATE PAYGO SCORECARDS.—The budgetary effects of this 

division shall not be entered on any PAYGO scorecard maintained 

for purposes of section 4106 of H. Con. Res. 71 (115th Congress). 

(c) CLASSIFICATION OF BUDGETARY EFFECTS.—Notwithstanding 

Rule 3 of the Budget Scorekeeping Guidelines set forth in the 

joint explanatory statement of the committee of conference accompanying Conference Report 105–217 and section 250(c)(7) and (c)(8) 

of the Balanced Budget and Emergency Deficit Control Act of 1985, 

the budgetary effects of this division shall be estimated for purposes 

of section 251 of such Act. 
H. R. 266—11 

This division may be cited as the ‘‘Additional Emergency Appropriations for Coronavirus Response’’. 

Speaker of the House of Representatives. 

Vice President of the United States and

President of the Senate.